KA
ARKG icon

Kovack Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Kovack Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,109
Closed -$310K – 613
2024
Q3 		$310K Sell
12,109
-1,023
-8% -$26K 0.03% 431
2024
Q2 		$308K Sell
13,132
-1,079
-8% -$27.2K 0.03% 413
2024
Q1 		$409K Sell
14,211
-128
-0.9% -$3.85K 0.05% 292
2023
Q4 		$470K Buy
14,339
+466
+3% +$12.7K 0.06% 310
2023
Q3 		$387K Buy
13,873
+830
+6% +$27.1K 0.05% 324
2023
Q2 		$445K Sell
13,043
-221
-2% -$6.95K 0.06% 319
2023
Q1 		$399K Buy
13,264
+911
+7% +$28.2K 0.05% 335
2022
Q4 		$349K Sell
12,353
-230
-2% -$7.3K 0.05% 371
2022
Q3 		$414K Sell
12,583
-73
-0.6% -$2.68K 0.06% 326
2022
Q2 		$399K Sell
12,656
-613
-5% -$21.4K 0.05% 376
2022
Q1 		$609K Sell
13,269
-37
-0.3% -$1.76K 0.06% 339
2021
Q4 		$815K Buy
13,306
+6,492
+95% +$449K 0.08% 277
2021
Q3 		$509K Buy
6,814
+758
+13% +$63.6K 0.06% 374
2021
Q2 		$560K Buy
6,056
+1,140
+23% +$96.9K 0.06% 327
2021
Q1 		$436K Buy
+4,916
New +$488K 0.06% 349
2020
Q3 		– Sell
-4,939
Closed -$258K – 529
2020
Q2 		$258K Sell
4,939
-19,461
-80% -$835K 0.05% 352
2020
Q1 		$763K Buy
24,400
+349
+1% +$11.7K 0.18% 135
2019
Q4 		$806K Buy
24,051
+2,217
+10% +$70.4K 0.14% 169
2019
Q3 		$645K Buy
21,834
+14,920
+216% +$485K 0.13% 182
2019
Q2 		$238K Buy
+6,914
New +$222K 0.05% 354
2018
Q2 		– Sell
-10,204
Closed -$263K – 432
2018
Q1 		$263K Buy
+10,204
New +$276K 0.07% 346

Other funds holding ARKG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Kovack Advisors's ARKG Position: Q4 2024 in Review

Kovack Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 12,109 shares — an estimated $310K sold.

Kovack Advisors first reported a position in ARKG in Q1 2018 and held it in 21 quarters. The position peaked at $815K in Q4 2021. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

  • Kovack Advisors reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
  • Kovack Advisors sold 12,109 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $310K.
  • Kovack Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2018 and held it in 21 quarters.
  • Kovack Advisors's ARK Genomic Revolution ETF position peaked at $815K in Q4 2021.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on Kovack Advisors's 13F filing for Q4 2024, filed 5 Feb 2025.